Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Bioscience entities : Kering save search
Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2021 Net Product Sales Results and Future Program Milestones
Published: 2022-01-06 (Crawled : 00:00) - biospace.com/
PPRUF | News | $340.0 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 2.64%
H: 0.0%
C: -0.39%
PPRUY | News | $33.79 -0.11% 360K
|
Manufacturing
|
| O: -0.99%
H: 0.0%
C: -1.16%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 1.0%
H: 0.0%
C: 0.0%
NBIX | News M | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
sales bioscience milestone
Neurocrine Biosciences Presents New INGREZZA® (valbenazine) Data at Psych Congress 2021
Published: 2021-11-01 (Crawled : 15:00) - biospace.com/
PPRUF | News | $340.0 37.56% 1.5K
|
Consumer Non-Durables
|
| O: -0.13%
H: 1.18%
C: 1.18%
PPRUY | News | $33.79 -0.11% 360K
|
Manufacturing
|
| O: -0.11%
H: 0.94%
C: 0.94%
NBIX | News M | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 0.09%
H: 2.38%
C: 0.68%
bioscience
Aura Biosciences Expands Executive Leadership Team and Board of Directors
Published: 2021-09-29 (Crawled : 12:00) - biospace.com/
PPRUF | News | $340.0 37.56% 1.5K
|
Consumer Non-Durables
|
| O: -0.98%
H: 1.43%
C: -3.59%
PPRUY | News | $33.79 -0.11% 360K
|
Manufacturing
|
| O: 0.88%
H: 0.0%
C: -1.26%
bioscience
Gainers vs Losers
| 65% | 35% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
ILAG | $0.51 6.03% 29.06% 430K
|
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.